ArticleCancer cell2025
A first-in-class EGFR-directed KRAS G12V selective inhibitor.
Lyla J Stanland et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleCancer cell2025
Lyla J Stanland et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.